Mason Joe

created a new article

16 w - Translate

The RNA targeting small molecule therapies market is projected to be worth around USD 8.3 billion in 2030 | #rna therapeutics market # RNA targeting small molecules # RNA Targeting Market # RNA therapeutics market Size

The RNA targeting small molecule therapies market is projected to be worth around USD 8.3 billion in 2030

In 2030, close to 40% of the market revenues are expected to be generated from sales of therapeutics that are intended to target oncological disorders.

Comment

created a new article

16 w - Translate

Inhaled and Intranasal Products Contract Service Providers Market | #inhaled products # intranasal products # inhalation drug delivery # intranasal drug delivery

Inhaled and Intranasal Products Contract Service Providers Market

As the figure represents, more than 70 % of the companies which offer contract manufacturing services

Comment

created a new article

16 w - Translate

Avastin® (Bevacizumab) Biosimilars, By Roots Analysis | #"Global Bevacizumab biosimilar market # Bevacizumab # Avastin # Bevacizumab Colon Cancer Drugs # Kidney Cancer Drugs # Lung Cancer Drugs"

Avastin® (Bevacizumab) Biosimilars, By Roots Analysis

This substantial erosion in sales is evidence of the market capturing potential of biosimilars

Comment

created a new article

18 w - Translate

Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases (ZFNs) | #gene editing market # crispr # zinc-finger nucleases # TALENs # genome editing # gene editing # gene editing technologies # meganuclease

Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases (ZFNs)

Clinical research activity, in terms of number of trials registered, is reported to have increased in the last five years.

Comment

created a new article

18 w - Translate

Regulatory T-Cell Therapies (Tregs) Market | #regulatory t-cell therapy # car-treg therapy # regulatory t-cell culture # treg cell therapies companies # treg cells # Treg cell therapies

Regulatory T-Cell Therapies (Tregs) Market

A detailed assessment of the current market landscape of drug developers engaged in the development of regulatory T-cell therapies.

Comment